Prostaglandin H Synthase-2-catalyzed Oxygenation of 2-arachidonoylglycerol is More Sensitive to Peroxide Tone Than Oxygenation of Arachidonic Acid
Overview
Authors
Affiliations
The endocannabinoid, 2-arachidonoylglycerol (2-AG), is a selective substrate for the inducible isoform of prostaglandin H synthase (PGHS), PGHS-2. Its turnover leads to the formation of glyceryl esters of prostaglandins (PG-Gs), a subset of which elicits agonism at unique, as yet unidentified, receptors. The k(cat)/K(m) values for oxygenation of arachidonic acid (AA) and 2-AG by PGHS-2 are very similar, but the sensitivities of the two substrates to peroxide-dependent activation have not been compared. 15-Hydroperoxy derivatives of AA and 2-AG were found to be comparable in their ability to serve as substrates for the peroxidase activities of PGHS-2, PGHS-1, and glutathione peroxidase (GPx). They also were comparable in the activation of AA oxygenation by cyanide-inhibited PGHS-2. However, oxygenation of 2-AG was significantly suppressed relative to AA by the presence of GPx and GSH. Furthermore, 2-AG oxygenation by peroxidase-deficient H388YmPGHS-2 was much less efficient than AA oxygenation. Wild-type rates of 2-AG oxygenation were restored by treatment of H388YmPGHS-2 with hydroperoxide derivatives of AA or 2-AG. RNAi silencing of phospholipid hydroperoxide-specific GPx (GPx4) in NIH/3T3 cells led to increases in cellular peroxidation and in the levels of the isoprostane product, 8-epi-PGF(2α). GPx4 silencing led to 2-4-fold increases in PG-G formation but no change in PG formation. Thus, cellular peroxide tone may be an important determinant of the extent of endocannabinoid oxygenation by PGHS-2.
Fan W, Wang D, Yan L, Yuan Z Curr Pharm Des. 2024; 30(22):1771-1785.
PMID: 38798215 DOI: 10.2174/0113816128295774240523062258.
A guide to ferroptosis in cancer.
Yapici F, Bebber C, von Karstedt S Mol Oncol. 2024; 18(6):1378-1396.
PMID: 38590214 PMC: 11161738. DOI: 10.1002/1878-0261.13649.
A network-based pharmacological study on the mechanism of action of muscone in breast cancer.
Zhao Y, Tao S, Wang Q, Liu Y, Yang W, Zhang S Transl Cancer Res. 2022; 11(5):1195-1206.
PMID: 35706803 PMC: 9189209. DOI: 10.21037/tcr-22-667.
Kohansal F, Mobed A, Ansari R, Hasanzadeh M, Ahmadalipour A, Shadjou N RSC Adv. 2022; 12(22):14154-14166.
PMID: 35558840 PMC: 9092357. DOI: 10.1039/d2ra00380e.
Harmaline Analogs as Substrate-Selective Cyclooxygenase-2 Inhibitors.
Uddin M, Xu S, Crews B, Aleem A, Ghebreselasie K, Banerjee S ACS Med Chem Lett. 2020; 11(10):1881-1885.
PMID: 33062168 PMC: 7549255. DOI: 10.1021/acsmedchemlett.9b00555.